Evidence map›Paper›PMID 37456972›Full record

ArticleWorld journal of methodology2023

Preferences for oral-

Victor Abiola Adepoju, Winifred Imoyera, Ali Johnson Onoja

Open access · diamondAbstract readScoping Review
In one paragraph

Article in World journal of methodology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Victor Abiola AdepojuDepartment of HIV and Infectious Diseases, Jhpiego Nigeria, an affiliate of John Hopkins University, Abuja 900901, Federal Capital Territory, Nigeria. schrodinga05@yahoo.com.
Winifred ImoyeraDepartment of HIV and Infectious Diseases, Jhpiego Nigeria, an affiliate of John Hopkins University, Abuja 900901, Federal Capital Territory, Nigeria.
Ali Johnson OnojaResearch, African Health Project, Abuja 900901, Federal Capital Territory, Nigeria.
African Institute of Science and Technology · NGFederal Ministry of Health · NGMinistry of Environment · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe evidence on preferences for oral-

aimTo examine the existing literature on preferences for oral-

methodsDatabases such as PubMed, Medline, Google Scholar, and Web of Science were searched for articles published between January 2011 to October 2022. Articles must address preferences for oral-

resultsThe initial search revealed 2424 records, of which 8 studies were finally included in the scoping review. Pooled preference for blood-based HIVST was 48.8% (9%-78.6%), whereas pooled preference for oral HIVST was 59.8% (34.2%-91%) across all studies. However, for male-specific studies, the preference for blood-based HIVST (58%-65.6%) was higher than that for oral (34.2%-41%). The four studies that reported a higher preference for blood-based HIVST were in men. Participants considered blood-based HIVST to be more accurate and rapid, while those with a higher preference for oral HIVST did so because these were considered non-invasive and easy to use.

conclusionConsistently in the literature, men preferred blood-based HIVST over oral HIVST due to higher risk perception and desire for a test that provides higher accuracy coupled with rapidity, autonomy, privacy, and confidentiality, whereas those with a higher preference for oral HIVST did so because these were considered non-invasive and easy to use. Misinformation and distrust need to be addressed through promotional messaging to maximize the diversity of this new biomedical technology.

Indexed as

Blood-based human immunodeficiency virus self-testingHuman immunodeficiency virus self-testingOral human immunodeficiency virus self-testingPreferences

Identifiers

PMID37456972
PMCPMC10348079
OpenAlexW4381145074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.